F-1/A: Lytus Technologies Files F-1/A for Public Offering, Nasdaq Listing

Lytus Technologies Holdings PTV. Ltd. files an amended F-1 registration statement for a public offering of 1,000,000 common shares, seeking Nasdaq Capital Market listing.

Summary

• Lytus Technologies Holdings PTV. Ltd. is offering 1,000,000 common shares in a firm commitment underwritten public offering, with an expected price range of $5.00 to $7.00 per share.
• The company has applied to list its common shares on the Nasdaq Capital Market under the symbol LYT, with the closing of the offering contingent upon successful listing approval.
• Currently, the common shares are quoted on the OTCID under LYTHF, with a last reported sale price of $13.25 per share on December 9, 2025.
• A 1-for-2,500 reverse stock split became effective on September 26, 2025.
• The company operates primarily in India, offering linear content streaming/telecasting services and developing healthtech and fintech products, with over four million active users.
• Net proceeds of approximately $4.7 million (assuming a $5.00/share offering price) will be used to repay a $1.6 million promissory note to Yorkville and allocate $3.1 million for working capital and general corporate purposes.
• Total income for the fiscal year ended March 31, 2025, was $23,186,534, a 0.80% increase from $23,003,342 in FY2024.
• Net income after tax for FY2025 increased by 27% to $829,412, up from $653,174 in FY2024.
• Cash and cash equivalents significantly increased from $246,377 in FY2024 to $4,674,586 in FY2025.
• The company is an emerging growth company and will be a controlled company post-offering, with CEO Dharmesh Pandya controlling approximately 52% of the voting power.

Sentiment

Score: 7

Explanation: The company shows strong growth in net income and operating cash flow, and has clear strategic plans for expansion in high-growth sectors like telemedicine and fintech in India. The public offering and Nasdaq listing application are positive steps for capital access and visibility. However, the recent delisting from Nasdaq, the 'controlled company' status, and the inherent risks of operating in emerging markets and competitive industries temper the overall sentiment. The significant decrease in 'other income' for FY2025 also warrants attention.

Positives

• Net income after tax increased by 27% to $829,412 for the fiscal year ended March 31, 2025, compared to $653,174 in the prior year.
• Operating revenue increased by $1,764,144 (8.26%) for FY2025, primarily driven by higher carriage and placement fees and new consultancy services/unbilled revenue.
• Cash and cash equivalents saw a substantial increase from $246,377 in FY2024 to $4,674,586 in FY2025.
• Net cash provided by operating activities more than doubled from $886,034 in FY2024 to $2,164,425 in FY2025.
• Finance costs decreased by 77% ($489,786 decrease) in FY2025 due to repayment of borrowings and extinguishment of warrant liabilities.
• The company has a clear strategic focus on expanding its service and product portfolio into high-growth areas like healthtech and fintech, and enhancing its technology platform.
• The acquisition of a 51% interest in Sri Sai Cable Network and plans to upgrade its infrastructure (Fiber to the Home, GPON) are expected to offer broadband/IPTV and value-added services.
• The company has commenced its broadband/IPTV and Fintech businesses, and is repurposing its local cable operator network for telemedicine and diagnostic centers in India.
• Management believes the proceeds from the public offering will be sufficient to satisfy cash needs for the next 12 months.
• The company has obtained an Internet Service Provider License, supporting its expansion into broadband services.

Negatives

• Total revenue growth was marginal at 0.80% for FY2025, despite an 8.26% increase in operating revenue, due to a significant 96.42% decrease in other income.
• Subscription income decreased by $649,754 (4.34%) in FY2025.
• Fiber use revenue decreased by $289,788 (100%) in FY2025.
• The company's common shares were delisted from Nasdaq on March 31, 2025, and now trade on OTCQB, which may negatively impact stock price and liquidity.
• There is no assurance that the initial Nasdaq listing application will be approved, and if not, the public offering will be terminated.
• The company identified material weaknesses in its internal control over financial reporting and ineffective disclosure controls and procedures as of March 31, 2025.
• The company has a limited operating history and rapid growth, making future prospects difficult to evaluate and increasing investment risk.
• Revenues and expenses are difficult to predict and can fluctuate significantly, increasing the likelihood of results falling below expectations.
• The company is a 'controlled company' and a 'foreign private issuer,' allowing it to rely on exemptions from certain Nasdaq corporate governance requirements, which may afford less protection to shareholders.
• CEO Dharmesh Pandya controls approximately 52% of voting power post-offering, allowing substantial influence over corporate matters, potentially discouraging change of control.
• The company has broad discretion in the use of net proceeds, which may not yield a favorable return.
• The common share price has been volatile and could continue to fluctuate widely, potentially leading to loss of investment value.
• No plans to pay dividends in the foreseeable future.
• A substantial portion of business and operations is in India, exposing the company to regulatory, economic, social, and political uncertainties.
• Restrictions on foreign investment in India may prevent future acquisitions or investments.
• The telehealth market is immature and volatile, and market acceptance of services is uncertain.
• The company faces potential liability risks inherent to the healthcare industry, and insurance may not be adequate.
• Software failures, breakdowns in systems, or failure to implement enhancements could harm the business.
• Reliance on third-party systems and service providers poses risks of disruption.
• The company may incur substantial expense to further develop its platform, which may not become sufficiently successful.
• Difficulty in obtaining and protecting intellectual property rights could harm the brand and business.
• The company operates in highly competitive industries, facing larger and more capitalized competitors.
• Dependence on key existing and future personnel, particularly CEO Dharmesh Pandya, poses a risk if their services are lost.

Risks

• Inability to predict or sustain an active public trading market for common shares.
• Common shares are currently quoted on the OTCID, which may have an unfavorable impact on stock price and liquidity.
• No assurance that the initial Nasdaq Capital Market listing application will be approved; the public offering will be terminated if not approved.
• Inability to satisfy ongoing Nasdaq listing requirements if common shares become listed.
• U.S. broker-dealers may be discouraged from effecting transactions in common shares if they are considered 'penny stock'.
• Substantial future sales of common shares, or the perception of such sales, may depress the stock price and cause dilution.
• Broad discretion in the use of net proceeds from the public offering, which may not yield a favorable return on investment.
• Common share price could continue to be volatile, leading to potential loss of investment value.
• As a foreign private issuer, disclosure obligations differ from U.S. domestic reporting companies, potentially making it more difficult for investors to evaluate performance.
• As a controlled company, the company can rely on exemptions from certain Nasdaq corporate governance requirements, which may afford less protection to shareholders.
• The chief executive officer and principal shareholder owns a significant percentage of common shares and can exert substantial control over matters subject to shareholder approval.
• Dilution may result from the issuance of common shares underlying convertible notes at a discount to market price.
• Shareholder protections under BVI law may be fewer than under U.S. law.
• Potential classification as a Passive Foreign Investment Company (PFIC) could result in adverse U.S. tax consequences to U.S. investors.
• Limited operating history and rapid growth make evaluating current business and future prospects difficult and increase investment risk.
• Revenues and expenses are difficult to predict and can fluctuate significantly, increasing the likelihood of results falling below expectations.
• Risks related to the storage of customer confidential information and cybersecurity incidents.
• An economic slowdown or factors affecting the economic health of the United States, India, or the IT, healthcare, and streaming industries may adversely affect the business.
• Liability issues are inherent to the healthcare industry, and insurance is expensive and difficult to obtain.
• Failure to develop and maintain an effective system of internal control over financial reporting and disclosure controls and procedures.
• Reliance on information technology; any failure to adapt to technological developments or industry trends could harm the business.
• Reliance on third-party systems and service providers; any disruption or adverse change in their businesses could have a material adverse effect.
• Potential intellectual property infringement claims, which may be expensive to defend and disrupt business.
• Platforms and internal systems rely on highly technical software, and undetected errors could adversely affect the business.
• Dependence on the ability to maintain relationships with business partners and other third parties.
• No plans to pay dividends in the foreseeable future.
• A substantial portion of business and operations is located in India, subject to regulatory, economic, social, and political uncertainties.
• Restrictions on foreign investment in India may prevent future acquisitions or investments.
• The telehealth market is immature and volatile; negative publicity or lack of competitiveness could harm business growth.
• Legal challenges to the business model or actions restricting the ability to provide services in certain jurisdictions.
• Need to increase the size of the organization and potential difficulties in managing growth.
• Inability to continue to identify and exploit new market opportunities could lead to declining future revenues.
• Difficult market conditions, economic conditions, and geopolitical uncertainties could adversely affect the business.
• Changing laws, rules, and regulations and legal uncertainties, including adverse application of tax laws, may adversely affect business and financial performance.
• Infrastructure in India may not be upgraded to support higher internet penetration, requiring additional investments.
• Results of operations are subject to fluctuations in currency exchange rates.
• Inability to obtain additional financing, if needed, on acceptable terms or at all.
• Operating in highly competitive industries with larger, more capitalized competitors.
• Dependence on key existing and future personnel, particularly Dharmesh Pandya.
• Difficulty in recruiting and retaining experienced therapists for healthcare services.
• Healthcare provider licensing and credentialing, a cost of providing professional services, can negatively impact margins.
• Failure to maintain or enhance consumer awareness of the brand could have a material adverse effect.
• Inability to successfully implement growth strategies or pursue strategic partnerships and acquisitions.

Future Outlook

The company plans to expand its service and product portfolio to enhance cross-selling opportunities, focusing on healthtech and fintech. It intends to invest in technology to strengthen its platform, expand into new geographic markets, and pursue selective strategic partnerships and acquisitions. A subscription-based remote patient monitoring device service is expected to launch in India in the second half of 2025, with similar devices planned for the U.S. The rollout of local health centers and diagnostic centers in India is also expected to commence in the second half of 2025 and take 24 months to complete. Fintech services will initially target Sri Sai customers, with plans to offer e-wallet payments, credit cards, and microloans, eventually expanding across all business verticals. Lytus Studios aims to produce original content for the Lytus Play streaming platform, and Lytus Cloud will offer various cloud infrastructure services to enterprise clients. Management believes the proceeds from this offering will be sufficient to satisfy cash needs for the next 12 months.

Management Comments

• "We are focused on consolidating our subscriber base for future technology services, such as healthtech and fintech services, while continuing to develop our technology platform for a better service experience."
• "We believe that our strong customer base and expansive market presence position us to expand our portfolio of offerings."
• "We believe that our deep understanding and local expertise have enabled us to create solutions that address the needs and preferences of our consumers in the most comprehensive and efficient way."
• "Management believes that the proceeds from this offering will be sufficient to satisfy the Company's cash needs for the next 12 months."
• "We strive to continue exceeding our customers expectations by enhancing our network capacity and coverage while broadening service offerings."

Industry Context

The company operates within India's dynamic digital services landscape, encompassing streaming, telemedicine, and financial technology. The IPTV market in India is experiencing significant growth, driven by the rising popularity of video-on-demand, increasing smartphone penetration, lower data tariffs, rapid urbanization (approximately 33% in India), and supportive government initiatives for digital transformation. The telehealth sector in India is nascent but expanding, with recent Telemedicine Practice Guidelines (March 2020) providing a clearer legal framework. The company faces intense competition from major players in each segment, including JioHotstar and Netflix in streaming, Practo and Apollo 24/7 in telemedicine, and Amazon Pay and JioMoney in fintech. The low internet penetration in many Indian regions presents a substantial opportunity for the company to provide online services to underserved populations, aligning with its strategy to upgrade infrastructure and expand offerings.

Comparison to Industry Standards

• The company's plan to upgrade existing cable networks to Fiber to the Home (FTTH) and Gigabit Passive Optical Networks (GPON) aligns with modern broadband infrastructure standards, enhancing service quality and capacity.
• The transformation of traditional set-top boxes into Android boxes positions the company among a select few in India offering such integrated platform access, providing a competitive edge in user experience.
• The telemedicine business's intention to use remote patient monitoring devices from HIPAA and U.S. FDA compliant vendors indicates adherence to international healthcare technology and regulatory standards.
• The focus on artificial intelligence (AI) and machine learning (ML) for telemedicine operations is consistent with broader industry trends aimed at improving efficiency and service delivery in healthcare technology.
• The company's operations in India are subject to extensive governmental laws and regulations, including those from the Ministry of Telecommunications and the Telecom Regulatory Authority of India (TRAI), demonstrating compliance with local industry-specific regulatory frameworks.
• The Fintech business is actively ensuring compliance with Indian banking laws and regulations, which is crucial for operating in the regulated financial technology sector.

Corporate Governance

Legal Proceedings

• On May 22, 2020, Securitax Ltd. and Optimal US Logistics, LLC filed a complaint against CEO Dharmesh Pandya in the Circuit Court of the Fourth Judicial Circuit in Florida, alleging breach of contract and fiduciary duty, claiming $854,000 in damages.
• The company believes these claims are false and frivolous, asserting they are in response to a UK lawsuit filed by Nextecworks (formerly Lituus Technologies Limited) against the plaintiffs for $40 million for fraudulent misrepresentation, breach of contract, and illegally holding 1% equity.
• Mr. Pandya is actively defending these claims, and mediation is ongoing.
• Mr. Pandya is a shareholder of Nextecworks but holds no executive position, and Nextecworks has no relation to the company or its businesses.
• No other material legal proceedings are currently pending or threatened against the company or its executive officers/directors.

Related Party Transactions

• Subscription income from Significant Influence Entity KMP: $518,795 (FY2025).
• STB Installation charges from Significant Influence Entity KMP: $48,445 (FY2025).
• Loan taken from KMP: $272,365 (FY2025).
• Loan repayment to KMP: $1,543,653 (FY2025).
• Commission expenses from Significant Influence Entity KMP: $1,305,186 (FY2025).
• Bandwidth charges from Significant Influence Entity KMP: $24,339 (FY2025).
• Sales/Purchase of materials from Significant Influence Entity KMP: $8,602 (FY2025).
• Fiber Maintenance Expense from Significant Influence Entity KMP: $1,502 (FY2025).
• Consultancy Services (Revenue) from Significant Influence Entity KMP: $1,061,622 (FY2025).
• IT support Charges from Significant Influence Entity KMP: $5,908 (FY2025).
• Remuneration to KMP: $141,797 (FY2025).
• Rent paid/provided to KMP: $7,802 (FY2025).
• Investment in CCD of Subsidiary: $3,817,490 (FY2025).
• Reimbursement of expenses to KMP: $92,246 (FY2025).
• Loans and Advances given to Significant Influence Entity KMP: $239,684 (FY2025).
• Loans and Advances received back from Significant Influence Entity KMP: $214,458 (FY2025).
• Advances for network acquisition from Significant Influence Entity KMP: $16,661 (FY2025).
• Loan taken from Relatives of KMP: $124,918 (FY2025).
• Loan repayment to Relatives of KMP: $19,012 (FY2025).
• Remuneration to Relatives of KMP: $38,286 (FY2025).
• Interest on loan from Relatives of KMP: $212 (FY2025).
• Outstanding Trade receivable from Significant Influence Entity KMP: $184,381 (as of March 31, 2025).
• Outstanding Trade Payables to Significant Influence Entity KMP: $2,862,917 (as of March 31, 2025).
• Outstanding Advance from Customers to Significant Influence Entity KMP: $5,853 (as of March 31, 2025).
• Outstanding Advances for network acquisition from Significant Influence Entity KMP: $4,012,167 (as of March 31, 2025).
• Outstanding Advances to suppliers from Significant Influence Entity KMP: $337,025 (as of March 31, 2025).
• Outstanding Other Loans & Advances from Significant Influence Entity KMP: $257,212 (as of March 31, 2025).
• Outstanding Borrowings from KMP: $164,124 (as of March 31, 2025).
• Outstanding Investment In Compulsory Convertible Debentures (Subsidiaries): $7,805,507 (as of March 31, 2025).
• Outstanding Options (Significant Influence Entity KMP): $91,813 (as of March 31, 2025).
• Outstanding Borrowings from Relatives of KMP: $31,019 (as of March 31, 2025).

Stakeholder Impact

• Shareholders face potential dilution from the public offering and future equity issuances, alongside risks of stock price volatility and the recent Nasdaq delisting. Benefits are anticipated from potential Nasdaq listing and strategic growth initiatives. The CEO's significant control (52% voting power) may limit minority shareholder influence, and no dividends are expected in the foreseeable future.
• Employees are impacted by the 2023 Employee Incentive Plan, with restricted common shares issued to a trust for future allocation to management and employees, aiming to attract, retain, and motivate personnel.
• Customers are expected to benefit from upgraded streaming and internet services (FTTH, GPON), new healthtech offerings (telemedicine, remote monitoring), and fintech services (e-wallet, microloans), as well as curated content from Lytus Studios.
• Suppliers and partners are crucial as the company relies on third-party systems, service providers, and content partners, with strategic partnerships being a key element of its growth strategy.
• Creditors will see a reduction in debt with the repayment of the $1.6 million promissory note to Yorkville, though existing debt agreements impose operating and financial restrictions on the company.

Next Steps

• Consummate the public offering, contingent on Nasdaq listing approval.
• Obtain Nasdaq Capital Market listing for common shares under symbol LYT.
• Repay $1.6 million outstanding under the promissory note to Yorkville.
• Utilize $3.1 million for working capital and general corporate purposes, including potential strategic transactions.
• Continue upgrading existing cable networks for Sri Sai Cable Network to deploy Fiber to the Home (FTTH) and Gigabit Passive Optical Networks (GPON).
• Launch subscription-based remote patient monitoring device service in India (second half of 2025).
• Purchase and install patient monitoring devices in the United States via Lytus Health (second half of 2025).
• Commence rollout of local health centers and diagnostic centers (LHCs) in India (second half of 2025, expected to take 24 months).
• Expand Fintech services to Sri Sai customers, including e-wallet payments, credit cards, and microloans.
• Produce original content for the Lytus Play streaming platform through Lytus Studios.
• Offer cloud infrastructure services through Lytus Cloud.
• Complete the acquisition of 51% of Sreedevi Digital Systems Private Limited (subsequent to reporting period).
• Address material weaknesses in internal control over financial reporting and improve disclosure controls and procedures.
• Hold next compensation committee meeting on or before September 30, 2025.

Key Dates

Recommendation

The company presents a mixed bag. While there's clear growth in net income and operating cash flow, and ambitious plans for expansion in high-growth sectors like telemedicine and fintech in India, the recent delisting from Nasdaq and the ongoing uncertainty of re-listing are significant concerns. The 'controlled company' status and potential for dilution also add to the risk profile. The current OTCID price of $13.25 is significantly higher than the proposed offering price range of $5.00-$7.00, which suggests a potential disconnect or a very different valuation basis. Given the volatility, regulatory uncertainties, and the need for successful execution of ambitious growth strategies, a 'Hold' recommendation is appropriate. Investors should monitor the Nasdaq listing outcome, the effectiveness of internal control remediation, and progress on new business initiatives before considering further investment.

Keywords

Streaming services, IPTV, Telemedicine, Fintech, India market, Public offering, Nasdaq listing, SEC filing, F-1/A, Lytus Technologies, Emerging growth company, Controlled company, Reverse stock split, Capital raise, Financial results, Corporate governance, Risk management, Digital content, Broadband, Healthcare technology, Financial technology, Subscriber base, International Financial Reporting Standards (IFRS)